LIT-001 is the first nonpeptide oxytocin receptor (OT-R) agonist (EC50=55 nM; Ki=226 nM). LIT-001 improves social interaction in a mouse model of autism.
IC50&Target
EC50: 55 nM (OT-R)
Ki: 226 nM (OT-R)
体外研究
In vitro signaling experiments, LIT-001 is a nonbiased OT-R agonist on the two main signaling pathways of this receptor, with minor antagonist effect on V1a and agonist effect on V1b receptors, observed at high concentrations only.
体内研究
LIT-001 (10-20 mg/kg; i.p.) alleviates core symptoms in the context of autism spectrum disorders (ASD ).
Animal Model:
Oprm1 mice (bred in house on a 50% 129SVPas–50% C57BL/6J hybrid background)
Dosage:
10, 20 mg/kg
Administration:
i.p.
Result:
Alleviated core symptoms in the context of ASD.
分子式
C30H34F3N7O4S
分子量
645.70
CAS号
2245072-21-1
运输条件
Room temperature in continental US; may vary elsewhere.